Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full …
WEBAug 23, 2021 — COMIRNATY is the first COVID-19 vaccine to be granted full approval by the FDA for individuals 16 years and older. The vaccine has also been authorized for emergency use in individuals 12 years and older and for a third dose in certain immunocompromised individuals.
Pfizer and BioNTech Announce Phase 3 Trial Data Showing High …
WEBOct 21, 2021 — The companies announced high efficacy and safety of a booster dose of their vaccine against COVID-19, based on a Phase 3 trial with more than 10,000 participants. The data will be submitted to regulatory agencies to support licensure and booster recommendations.
Pfizer and BioNTech Announce Positive Topline Data for mRNA …
WEBOct 26, 2023 — The companies report positive topline data from a Phase 1/2 study of their vaccine candidates against influenza and COVID-19. The vaccine candidates have a safety profile consistent with the COVID-19 vaccine and robust immune responses to influenza and SARS-CoV-2 strains.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
WEBDec 10, 2020 — BioNTech was the sponsor of the trial, manufactured the BNT162b2 clinical trial material, and contributed to the interpretation of the data and the writing of the manuscript.
Newsroom - BioNTech
WEBFind various media materials and useful information about BioNTech, the German biotechnology company developing mRNA-based vaccines and therapies. See photos and videos of BioNTech's activities in Africa, such as the inauguration of its mRNA manufacturing site in Kigali, Rwanda.
FDA Approves First COVID-19 Vaccine
WEBThe FDA announced the approval of Comirnaty, a COVID-19 vaccine from Pfizer-BioNTech, for individuals 16 years of age and older. The approval is based on updated data from a clinical trial that...
FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better …
WEBSep 11, 2023 — The FDA has approved and authorized updated mRNA vaccines from Moderna and Pfizer to better protect against Omicron variant XBB.1.5 and other circulating variants. The updated vaccines are...
Health Canada approves updated Pfizer COVID-19 vaccine - CTV …
WEB2 days ago — Pfizer-BioNTech's mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version that targeted the XBB.1.5 Omicron subvariant. Top health headlines, all in ...
Inside the hunt for a Covid-19 vaccine: how BioNTech made the …
WEB‘Immune system whisperers’ For BioNTech, the timing of Sars-Cov-2’s arrival is just one of several serendipitous events that led to the company’s unlikely success.
How BioNTech went from a little-known to creating Covid vaccine
WEBBioNTech founders were confident in the potential of their mRNA technology, which they knew could trigger a powerful immune response.